首页> 外文期刊>Breast Cancer Research and Treatment >Predicting sentinel lymph node metastasis in a Chinese breast cancer population: assessment of an existing nomogram and a new predictive nomogram
【24h】

Predicting sentinel lymph node metastasis in a Chinese breast cancer population: assessment of an existing nomogram and a new predictive nomogram

机译:预测中国乳腺癌人群前哨淋巴结转移:评估现有诺模图和新预测诺模图

获取原文
获取原文并翻译 | 示例
           

摘要

We assessed the MSKCC nomogram performance in predicting SLN metastases in a Chinese breast cancer population. A new model (the SCH nomogram) was developed with clinically relevant variables and possible advantages. Data were collected from 1,545 patients who had a successful SLN biopsy between March 2005 and November 2011. We validated the MSKCC nomogram in the modeling and validation group. Clinical and pathologic features of SLN biopsy in modeling group of 1,000 patients were assessed with multivariable logistic regression to predict the presence of SLN metastasis in breast cancer. The SCH nomogram was created from the logistic regression model and subsequently applied to 545 consecutive SLN biopsies. By multivariate analysis, age, tumor size, tumor location, tumor type, and lymphovascular invasion were identified as independent predictors of SLN metastasis. The SCH nomogram was then developed using the five variables. The new model was accurate and discriminating (with an AUC of 0.7649 in the modeling group) compared to the MSKCC nomogram (with an AUC of 0.7105 in the modeling group). The area under the ROC curve for the SCH nomogram in the validation population is 0.7587. The actual probability trends for the various deciles were comparable to the predicted probabilities. The false-negative rates of the SCH nomogram were 1.67, 3.54, and 8.20 % for the predicted probability cut-off points of 5, 10, and 15 %, respectively. Compared with the MSKCC nomogram, the SCH nomogram has a better AUC with fewer variables and has lower false-negative rates for the low-probability subgroups. The SCH nomogram could serve as a more acceptable clinical tool in preoperative discussions with patients, especially very-low-risk patients. When applied to these patients, the SCH nomogram could be used to safely avoid a SLN procedure. The nomogram should be validated in various patient populations to demonstrate its reproducibility.
机译:我们评估了MSKCC诺模图在预测中国乳腺癌人群SLN转移中的性能。开发了具有临床相关变量和可能优势的新模型(SCH诺模图)。从2005年3月至2011年11月间成功进行SLN活检的1,545例患者中收集了数据。我们在建模和验证组中验证了MSKCC列线图。通过多变量logistic回归评估1000例模型组SLN活检的临床和病理学特征,以预测乳腺癌中存在SLN转移。从逻辑回归模型创建SCH诺模图,然后将其应用于545个连续的SLN活检。通过多变量分析,年龄,肿瘤大小,肿瘤位置,肿瘤类型和淋巴管浸润被确定为SLN转移的独立预测因子。然后使用五个变量来开发SCH诺模图。与MSKCC nomogram(建模组的AUC为0.7105)相比,新模型准确且可区分(建模组的AUC为0.7649)。验证总体中SCH诺模图的ROC曲线下面积为0.7587。各个十分位数的实际概率趋势与预测概率相当。对于5%,10和15%的预测概率临界点,SCH诺模图的假阴性率分别为1.67、3.54和8.20%。与MSKCC诺模图相比,SCH诺模图具有更好的AUC,具有较少的变量,并且对于低概率子组具有较低的假阴性率。 SCH诺模图可以作为与患者(尤其是低危患者)进行术前讨论的更可接受的临床工具。当应用于这些患者时,SCH诺模图可用于安全地避免SLN手术。诺模图应在各种患者人群中进行验证,以证明其可重复性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号